Toxicological Risks of the Cobalt-Chromium Alloys in Dentistry: A Systematic Review.
Brigitte GrosgogeatAlina VaicelyteRémy GauthierChristine JanssenMarc Le BorgnePublished in: Materials (Basel, Switzerland) (2022)
Background: The toxicological risk of Co-Cr dental alloys is actually a sensitive subject with the European regulatory changes, namely regulation (EU) 2017/745 and annex VI to the CLP regulation (EC) 1972/2008. Objectives : The objective of this review is to conduct a rigorous analysis of the cytocompatibility of cobalt-chromium (Co-Cr) dental alloys. Considering various parameters such as cytotoxicity, type IV hypersensitivity reaction, sensitization, and irritation, we investigated evidence of toxicity of Co-Cr in human dental applications. Data sources : Specific search strategies were performed in three electronic databases, namely Medline , Embase , and Web of Science , using a main restriction in the search regarding the publication date (1995-2022). Study selection : Out of a total of 836 articles, only 21 studies were selected and analyzed according to PRISMA methodology. Results : Among them, 10 in vitro studies using human samples and 11 in vivo studies on human patients were distinguished. Most of the in vitro studies confirmed that Co-Cr alloys have a good cytocompatibility compared to Ni alloys. Regarding the in vivo studies, it appeared that Co-Cr could rarely cause sensitization, irritation, and allergic reactions. Reactions were mainly observed for people allergic to Co or Cr. Nevertheless, titanium-based materials showed better results. Conclusions : This study proposes a new state of the art on Co-Cr dental alloys and will thus be very useful for carrying out additional studies. Relevance : This review will help practitioners in their daily clinical choice.
Keyphrases
- case control
- endothelial cells
- end stage renal disease
- oral health
- chronic kidney disease
- public health
- induced pluripotent stem cells
- newly diagnosed
- ejection fraction
- transcription factor
- big data
- mass spectrometry
- patient reported outcomes
- electronic health record
- physical activity
- deep learning
- reduced graphene oxide
- atomic force microscopy
- decision making
- single molecule